Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 135

1.

Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their differential effects on intracranial hemorrhage and myocardial infarction?

Dale B, Eikelboom JW, Weitz JI, Young E, Paikin JS, Coppens M, Whitlock RP, Connolly SJ, Ginsberg JS, Hirsh J.

J Thromb Thrombolysis. 2013 Feb;35(2):295-301. doi: 10.1007/s11239-012-0857-9.

PMID:
23242974
[PubMed - indexed for MEDLINE]
2.

Preventing cardioembolic stroke in atrial fibrillation with dabigatran.

Weimar C, Hohnloser SH, Eikelboom JW, Diener HC.

Curr Neurol Neurosci Rep. 2012 Feb;12(1):17-23. doi: 10.1007/s11910-011-0229-4. Review.

PMID:
21960064
[PubMed - indexed for MEDLINE]
3.

Dabigatran and atrial fibrillation: the alternative to warfarin for selected patients.

[No authors listed]

Prescrire Int. 2012 Feb;21(124):33-6. Review.

PMID:
22413715
[PubMed - indexed for MEDLINE]
4.

Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study.

Larsen TB, Rasmussen LH, Skjøth F, Due KM, Callréus T, Rosenzweig M, Lip GY.

J Am Coll Cardiol. 2013 Jun 4;61(22):2264-73. doi: 10.1016/j.jacc.2013.03.020. Epub 2013 Apr 3.

PMID:
23562920
[PubMed - indexed for MEDLINE]
Free Article
5.

[Direct oral thrombin inhibitor, "dabigatran"].

Yasaka M.

Nihon Rinsho. 2013 Jan;71(1):113-8. Review. Japanese.

PMID:
23631181
[PubMed - indexed for MEDLINE]
6.

Inhibitory effect of apixaban compared with rivaroxaban and dabigatran on thrombin generation assay.

Wong PC, White A, Luettgen J.

Hosp Pract (1995). 2013 Feb;41(1):19-25. doi: 10.3810/hp.2013.02.1009.

PMID:
23466964
[PubMed - indexed for MEDLINE]
7.

Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial.

Hohnloser SH, Oldgren J, Yang S, Wallentin L, Ezekowitz M, Reilly P, Eikelboom J, Brueckmann M, Yusuf S, Connolly SJ.

Circulation. 2012 Feb 7;125(5):669-76. doi: 10.1161/CIRCULATIONAHA.111.055970. Epub 2012 Jan 3.

PMID:
22215856
[PubMed - indexed for MEDLINE]
Free Article
8.

[Expectation to and problems of thrombin inhibitor].

Uchiyama S.

Rinsho Shinkeigaku. 2011 Nov;51(11):1004-6. Japanese.

PMID:
22277458
[PubMed - indexed for MEDLINE]
9.

Implications of Dabigatran, a direct thrombin inhibitor, for oral surgery practice.

Davis C, Robertson C, Shivakumar S, Lee M.

J Can Dent Assoc. 2013;79:d74. Review.

PMID:
23920075
[PubMed - indexed for MEDLINE]
Free Article
10.

Myocardial ischemic events in 'real world' patients with atrial fibrillation treated with dabigatran or warfarin.

Larsen TB, Rasmussen LH, Gorst-Rasmussen A, Skjøth F, Rosenzweig M, Lane DA, Lip GY.

Am J Med. 2014 Apr;127(4):329-336.e4. doi: 10.1016/j.amjmed.2013.12.005. Epub 2013 Dec 19.

PMID:
24361757
[PubMed - indexed for MEDLINE]
11.

Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial.

Hart RG, Diener HC, Yang S, Connolly SJ, Wallentin L, Reilly PA, Ezekowitz MD, Yusuf S.

Stroke. 2012 Jun;43(6):1511-7. doi: 10.1161/STROKEAHA.112.650614. Epub 2012 Apr 5.

PMID:
22492518
[PubMed - indexed for MEDLINE]
Free Article
12.

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial.

Wallentin L, Yusuf S, Ezekowitz MD, Alings M, Flather M, Franzosi MG, Pais P, Dans A, Eikelboom J, Oldgren J, Pogue J, Reilly PA, Yang S, Connolly SJ; RE-LY investigators.

Lancet. 2010 Sep 18;376(9745):975-83. doi: 10.1016/S0140-6736(10)61194-4.

PMID:
20801496
[PubMed - indexed for MEDLINE]
13.

Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.

Freeman JV, Zhu RP, Owens DK, Garber AM, Hutton DW, Go AS, Wang PJ, Turakhia MP.

Ann Intern Med. 2011 Jan 4;154(1):1-11. doi: 10.7326/0003-4819-154-1-201101040-00289. Epub 2010 Nov 1.

PMID:
21041570
[PubMed - indexed for MEDLINE]
14.

Hemorrhagic complications in emergency department patients who are receiving dabigatran compared with warfarin.

Berger R, Salhanick SD, Chase M, Ganetsky M.

Ann Emerg Med. 2013 Apr;61(4):475-9. doi: 10.1016/j.annemergmed.2013.02.008.

PMID:
23522810
[PubMed - indexed for MEDLINE]
15.

Warfarin versus dabigatran: comparing the old with the new.

Abraham ME, Marcy TR.

Consult Pharm. 2012 Feb;27(2):121-4. doi: 10.4140/TCP.n.2012.121. Review.

PMID:
22330953
[PubMed - indexed for MEDLINE]
16.

Dabigatran, intracranial hemorrhage, and the neurosurgeon.

Awad AJ, Walcott BP, Stapleton CJ, Yanamadala V, Nahed BV, Coumans JV.

Neurosurg Focus. 2013 May;34(5):E7. doi: 10.3171/2013.2.FOCUS1323. Review.

PMID:
23634926
[PubMed - indexed for MEDLINE]
17.

[Waiting for the new oral anticoagulants: questions and answers about dabigatran].

Verdecchia P, Agnelli G.

G Ital Cardiol (Rome). 2013 Jan;14(1):35-45. doi: 10.1714/1207.13371. Review. Italian.

PMID:
23258203
[PubMed - indexed for MEDLINE]
18.

Reducing hemorrhagic complication by dabigatran via neurovascular protection after recanalization with tissue plasminogen activator in ischemic stroke of rat.

Kono S, Deguchi K, Omote Y, Yunoki T, Yamashita T, Kurata T, Ikeda Y, Abe K.

J Neurosci Res. 2014 Jan;92(1):46-53. doi: 10.1002/jnr.23302. Epub 2013 Nov 4.

PMID:
24265137
[PubMed - indexed for MEDLINE]
19.

The effect of dabigatran on the activated partial thromboplastin time and thrombin time as determined by the Hemoclot thrombin inhibitor assay in patient plasma samples.

Hapgood G, Butler J, Malan E, Chunilal S, Tran H.

Thromb Haemost. 2013 Aug;110(2):308-15. doi: 10.1160/TH13-04-0301. Epub 2013 Jun 20.

PMID:
23783268
[PubMed - indexed for MEDLINE]
20.

Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial.

Eikelboom JW, Wallentin L, Connolly SJ, Ezekowitz M, Healey JS, Oldgren J, Yang S, Alings M, Kaatz S, Hohnloser SH, Diener HC, Franzosi MG, Huber K, Reilly P, Varrone J, Yusuf S.

Circulation. 2011 May 31;123(21):2363-72. doi: 10.1161/CIRCULATIONAHA.110.004747. Epub 2011 May 16.

PMID:
21576658
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk